PEAK6
NEO icon

PEAK6’s NeoGenomics NEO Stock Holding History

PEAK6’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$148K Hold
20,000
– – ﹤0.01% 2340
2025
Q4 		$235K Buy
+20,000
New +$216K ﹤0.01% 2344

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

PEAK6's NEO Position: Q3 2025 in Review

PEAK6 sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 25,691 shares — an estimated $188K sold.

PEAK6 first reported a position in NEO in Q1 2025 and held it in 2 quarters. The position peaked at $188K in Q2 2025. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • PEAK6 reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
  • PEAK6 sold 25,691 NeoGenomics shares in Q3 2025, an estimated $188K.
  • PEAK6 first reported a position in NeoGenomics in Q1 2025 and held it in 2 quarters.
  • PEAK6's NeoGenomics position peaked at $188K in Q2 2025.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on PEAK6's 13F filing for Q3 2025, filed 14 Nov 2025.